Apo-Lisdexamfetamine recall in Canada: product quality issue
In plain language
This recall involves Apo-Lisdexamfetamine 30mg capsules sold in Canada. It's being recalled because some capsules may be broken or contain loose powder. Consult your healthcare provider before stopping use and follow the return steps in the official notice.
What to do
- Consult your healthcare provider before discontinuing use.
- Verify if your product is affected by checking the lot number.
- Contact the recalling firm, Apotex Inc., with any questions.
- Report any health product side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Apo-Lisdexamfetamine 30mg
Lot: VJ8877
Why this matters
Product quality issue
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: VJ8877
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product quality issue
What should consumers do?
Consult your healthcare provider before discontinuing use. Verify if your product is affected by checking the lot number. Contact the recalling firm, Apotex Inc., with any questions. Report any health product side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product quality issue
When was this product recalled?
This product was recalled on July 23, 2025.
Is the APO-LISDEXAMFETAMINE CAPSULES brand affected by this recall?
Yes, APO-LISDEXAMFETAMINE CAPSULES products are affected by this recall. This recall involves Apo-Lisdexamfetamine 30mg capsules sold in Canada. It's being recalled because some capsules may be broken or contain loose powder. Consult your healthcare provider before stopping use and follow the return steps in the official notice.